Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Aurora Cannabis

Tilray Brands

People who are involved in cannabis investing are keeping a positive outlook towards the future. Many feel this year will be big for investors and have the potential to see a rise in marijuana stocks. The start of a new year comes with many challenges and opportunities. Much of the obstacles to overcome have to do with better reform measures for legal cannabis operators. What this means is during 2024 many hope to see the end of cannabis prohibition.

3 Canadian Marijuana Stocks To Start The New Week

Cronos Group

Village Farms International

This week, the spotlight shines on Canadian cannabis stocks, marking an intriguing phase for investors and market watchers. Companies like Canopy Growth, Aurora Cannabis, and Tilray have become household names. They navigate the complex landscape of legal cannabis markets. Recent shifts in regulatory frameworks and market dynamics play a crucial role. These companies are on the brink of their quarterly earnings reports. This period could reveal significant insights into their operational efficiencies and market demand.

Investor Alert: Top Canadian Cannabis Picks for March 2024

SMITHS FALLS, ON , Feb. 22, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), a world-leading diversified cannabis company, today announced the introduction of five new pre-roll products across the Company's adult-use cannabis portfolio from brands 7ACRES and Hiway. "Forging ahead with our commitment to innovation, we're excited to offer new pre-roll offerings that meet consumers across a range of occasions and price points," said Dave Paterson, President, Canada, Canopy Growth.

CANOPY GROWTH LAUNCHES NEW PRE-ROLLS FROM 7ACRES AND HIWAY

Aurora Cannabis and Canopy Growth shares have fallen more than 99% in just five years. Both companies have been scaling back their operations and remain unprofitable.

2 Hugely Disappointing Stocks That Turned $10,000 Into Less Than $100 in Just 5 Years

Shareholders to vote on the creation of a new class of Exchangeable Shares, which is expected to be a critical step in strategy to accelerate Canopy Growth's entry into the over $50B 1 U.S. THC market. For any questions or assistance with voting, shareholders should contact Laurel Hill Advisory Group at 1-877-452-7184 (North American Toll Free) or 1‑416‑304‑0211 (Outside North America), or by email at assistance@laurelhill.com.

CANOPY GROWTH TO HOLD SPECIAL MEETING OF SHAREHOLDERS

Curaleaf Holdings, Inc.

The AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS ) has surged by nearly 30% year-to-date, showcasing the rejuvenated demand for cannabis stocks. Salient to the ETF's year-to-date performance has been the increased popularity of high-beta securities.

It's Time! 3 Overhyped Cannabis Stocks to Sell in February.

Canopy Growth's recent results show that the company has been making strides in improving its bottom line and decreasing cash burn. Top-line growth has been more difficult, given the company's divestment of BioSteel.

Do Canopy Growth's Improved Q3 Numbers Give Investors Hope for a Turnaround?

ARM Holdings PLC

Cadence Design Systems

Paramount Global

PepsiCo

Peloton

Starbucks

The Nasdaq continues to lead the three major stock indices and is currently near its all-time high. In fact, year-to-date, the Nasdaq is up 5%.

Exit Now! 7 Nasdaq Stocks to Sell in February 2024.

SNDL Inc.

The Canadian cannabis sector remains a hotbed of activity, drawing attention from investors globally. With legalization trends expanding, Canadian marijuana stocks are at the forefront. This week, several companies stand out due to their market movements and potential growth opportunities. Investors are keenly watching these stocks. They're looking for signs of strong financial health and strategic positioning. Overall, the global cannabis industry's expansion plays a crucial role in this interest.

Cannabis Market Movers: Canada's Top Picks for Mid-February 2024

MedMen Enterprises Inc.

Recent developments underscore the turbulent scenario investors are grappling with in the cannabis sphere, shedding light on the cannabis stocks to sell. While the U.S Drug Enforcement Administration mulls over changing marijuana's Schedule 1 status and the Health and Human Services leans towards relaxing federal restrictions, a sliver of hope emerges.

Exit Now! 3 Cannabis Stocks to Sell in February 2024

Canopy Growth Corporation (TSX:WEED, NYSE:CGC) showcased signs of financial improvement despite reporting a net loss, driven by increased revenue from its Canadian cannabis business and plans to advance its Canopy USA strategy for entry into the U.S. market.

Canopy Growth reduces net loss, eyes US market entry

Roundhill Cannabis ETF

Canopy Growth Corporation (CGC) Q3 2024 Earnings Call Transcript

Canopy Growth Corp. CGC, -4.86% WEED, -4.79% said Friday it plans to seek approval from shareholders for a plan to close its acquisitions of cannabis-touching, U.S.-based businesses under the Canopy USA name. The Canadian cannabis company said it expects to file a definitive proxy with the SEC for Canopy USA on or about Feb. 13 for an April 12 shareholder vote on the structure.

Canopy Growth seeking shareholder approval for Canopy USA

Canada adult-use cannabis business-to-business net revenue up 9% year-over-year; Canada medical cannabis net revenue up 11% year-over-year Focused execution drove sustained margin improvement with second quarter of consolidated gross margins exceeding 30% Canopy USA strategy moving forward; special shareholder meeting scheduled for April 12, 2024 SMITHS FALLS, ON , Feb. 9, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today announces its financial results for the third quarter ended December 31, 2023. All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.

Canopy Growth Reports Third Quarter Fiscal Year 2024 Financial Results; Achieves Third Quarter of Sequential Revenue Growth across Canada Cannabis Businesses and a Record Quarter for Medical Sales

BlackBerry

GameStop

While meme stocks continue to exist, their heyday appears behind us. Many of the best-known meme stocks that ran up the most in 2021 at the peak of the last market frenzy are now a pale shadow of their former selves.

3 Doomed Meme Stocks to Dump Before They Dive: February 2024

As we navigate through 2024, the Canadian cannabis sector and top marijuana stocks remain a hotbed of investment opportunities. With Canada at the forefront of cannabis legalization, several companies have emerged as key players. Overall, these firms range from large-scale producers to niche market innovators. Investors are keenly watching these stocks. This week, particular attention is on those demonstrating strong financial health, strategic partnerships, and innovative product lines. Amidst evolving regulations, these companies are poised for significant movements.

Top Picks for Canada's Cannabis Sector This February

Canopy Growth Corporation (CGC) closed the most recent trading day at $4.79, moving -0.83% from the previous trading session.

Canopy Growth Corporation (CGC) Sees a More Significant Dip Than Broader Market: Some Facts to Know

GrowGeneration Corp

OrganiGram Holdings Inc.

Given recent news items regarding the federal legalization of cannabis, you may think now is the time to be thinking about which cannabis stocks to buy, not which cannabis stocks to sell. Yes, the release of a letter from the U.S. Department of Health and Human Services, recommending that marijuana be rescheduled as a Schedule III drug, may be seen as signs of marijuana legalization progress.

7 Cannabis Stocks to Sell as the Industry Faces Legal Uncertainty in 2024

SMITHS FALLS, ON , Jan. 26, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter fiscal year 2024 ended December 31, 2023 before financial markets open on February 9, 2024. Following the release of its third quarter fiscal year 2024 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and Judy Hong, CFO on February 9, at 10AM  Eastern Time.

Canopy Growth to Report Third Quarter Fiscal 2024 Financial Results on February 9, 2024

Canopy Growth's cash balance has fallen sharply in just six months. The company's rate of cash burn implies it must raise more money to keep the business afloat.

What Would a Cash Crunch for Canopy Growth Mean for Investors?

SMITHS FALLS, ON , Jan. 24, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), a world-leading diversified cannabis company, today announced the introduction of new product offerings across the Company's adult use and medical cannabis portfolio, including new Tweed softgels and oils featuring minor cannabinoids, a large format flower offering from Tweed, as well as new medical exclusive pre-roll products from 7ACRES and Spectrum Therapeutics. "In addition to launching new flower products, we're making it easier to access CBD and minor cannabinoids in convenient oil and softgel formats to support wellness-minded consumers looking to start the year feeling their best," said Dave Paterson, President, Canada, Canopy Growth.

CANOPY GROWTH KICKS OFF THE NEW YEAR WITH NEW PRODUCTS FROM TWEED, 7ACRES, AND SPECTRUM THERAPEUTICS

Scotts Miracle-Gro

With almost the first month of 2024 gone legal cannabis is put on the front lines once again. Over the next several months we will see more states try to not only pass legalization measures but improve upon existing laws. Although cannabis is still federally illegal more than half of the US has legalized cannabis in some form. Whether it is a recreational market or a medical market being able to operate legally is a major win. Yet it is only one of the many pieces to the framework of legal cannabis.

This Is Why Marijuana Stocks Recover From New Cannabis Laws

Canopy Growth Corporation (CGC) reachead $4.41 at the closing of the latest trading day, reflecting a +0.92% change compared to its last close.

Canopy Growth Corporation (CGC) Outperforms Broader Market: What You Need to Know

Cannabis businesses could soon grow quickly once again. Canopy Growth is working to become more efficient.

Better Cannabis Stock: Canopy Growth vs. Tilray Brands

Cannabis ETFs are garnering attention in 2024 as the industry shows promising growth. Key players like MJ, MSOS, and CNBS dominate this sector. These ETFs offer diversified exposure to cannabis-related stocks. This includes companies involved in cultivation, production, and retail. The U.S. cannabis industry has seen remarkable growth. Statistics reveal a projected market size of over $30 billion by 2025. This growth is fueled by expanding legalization and increased consumer acceptance. Investors are increasingly attracted to this sector for its high-growth potential. However, the industry faces regulatory challenges and market volatility.

News for Canopy Growth Stock (CGC)